Given that RIPK3 is a key signaling molecule in necroptosis-related pathways, the present study compared the differences in cardiac hypertrophy presentation between WT mice and RIPK3−/− mice and mice treated with the RIPK3 inhibitor GSK'872. The gene discussed is RIPK3; the disease is cardiac hypertrophy.